Tscan Therapeutics Inc (TCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -69,605 | -46,608 | -22,563 | -66,221 | -47,498 |
| Depreciation Amortization | 4,081 | 2,795 | 1,499 | 5,137 | 3,653 |
| Accounts receivable | N/A | -31,926 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 589 | 862 | 495 | 528 | 114 |
| Other Working Capital | 23,804 | -4,595 | -3,884 | -10,230 | -9,946 |
| Other Operating Activity | 3,539 | 33,863 | 866 | 4,283 | 3,184 |
| Operating Cash Flow | $-37,592 | $-45,609 | $-23,587 | $-66,503 | $-50,493 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,677 | -1,258 | -838 | -4,225 | -2,848 |
| Purchase Of Investment | -59,995 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-62,672 | $-1,258 | $-838 | $-4,225 | $-2,848 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 29,354 | 29,354 |
| Common Stock Issued | 135,424 | 135,676 | N/A | 326 | 124 |
| Other Financing Activity | 0 | 0 | 0 | -324 | -230 |
| Financing Cash Flow | $135,424 | $135,676 | $N/A | $29,356 | $29,248 |
| Beginning Cash Position | 125,064 | 125,064 | 125,064 | 166,436 | 166,436 |
| End Cash Position | 160,224 | 213,873 | 100,639 | 125,064 | 142,343 |
| Net Cash Flow | $35,160 | $88,809 | $-24,425 | $-41,372 | $-24,093 |
| Free Cash Flow | |||||
| Operating Cash Flow | -37,592 | -45,609 | -23,587 | -66,503 | -50,493 |
| Capital Expenditure | -2,677 | -1,258 | -838 | -4,225 | -2,848 |
| Free Cash Flow | -40,269 | -46,867 | -24,425 | -70,728 | -53,341 |